F584-1525 Screening compound: ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate

F584-1525 Screening compound: ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate
F584-1525 Screening compound: ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate alternative view

Chemical Structure Depiction of ChemDiv screening compound F584-1525
ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F584-1525

Molecular Formula

C24H31N5O5 (C24 H31 N5 O5)

Compound Name

ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate

IUPAC name

ethyl 3-{[1-methyl-3-(morpholine-4-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carbonyl]amino}-3-phenylpropanoate

SMILES

CCOC(CC(c1ccccc1)NC(N(CC1)Cc2c1n(C)nc2C(N1CCOCC1)=O)=O)=O

InChI

InChI=1S/C24H31N5O5/c1-3-34-21(30)15-19(17-7-5-4-6-8-17)25-24(32)29-10-9-20-18(16-29)22(26-27(20)2)23(31)28-11-13-33-14-12-28/h4-8,19H,3,9-16H2,1-2H3,(H,25,32)/t19-/m0/s1

InChI Key

ZQQUENFEHOHHLM-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27177450

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.54

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.236

Distribution Coefficient, logD

1.236

Water Solubility, LogSw

-2.02

Polar Surface Area

86.055

Acid Dissociation Constant (pKa)

14.46

Base Dissociation Constant (pKb)

8.39

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

F584-1525 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Integrin Receptors Targeted library (1715 compounds)

PI3K-Targeted Library (17255 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Others
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with F584-1525 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F584-1525?
Check Price and Availability of F584-1525, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F584-1525 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F584-1525
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F584-1525
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F584-1525 available by request